Expanding at a CAGR of 3.4% from 2022 to 2032, the global knotless tissue control devices market is projected to secure a market value worth US$ 672.6 Million by 2032. In 2022, the market is projected at US$ 465.6 Million.
The growth of the market can be attributed to the increasing demand for minimally invasive procedures and growing technological advancement in the field.
| Report Attributes | Details |
|---|---|
| Projected Market Value (2022) | US$ 465.6 Million |
| Anticipated Forecast Value (2032) | US$ 672.6 Million |
| Estimated Growth Rate (2022 to 2032) | 3.4% |
Players in the market are focusing to develop their devices, which is projected to augment the market size in the forecast period. For instance, Ethicon announced the launch of STRATAFIX Spiral PDS Plus and STRATAFIX Spiral Monocryl Plus Knotless Tissue Control Devices. With the development of these two new suture technologies to the STRATAFIX Family of Knotless Tissue Control Devices, Ethicon has produced the most comprehensive knotless suture for surgeons in the USA Such factors are expected to benefit the market in the coming time.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Benefits offered by knotless tissue control devices such as offering distribution of tension along the wound, simplified knot tying, and reduced knot-related complications, are expected to boost its demand in healthcare infrastructures.
An increasing number of surgical procedures is anticipated to benefit the market in the assessment period. Growing cases of knee replacements, bypass surgeries, hip replacements, and cosmetic surgeries are likely to drive the industry in the coming years. According to a study published by the National Centre for Biotechnology Information, there are about 30% of aged people fall because of difficulty in walking, which is the primary cause of knee replacement surgeries.
The launch of efficient devices by players in the market is expected to strengthen the industry. In September 2020, Smith & Nephew launched HELICOIL knotless sutures that function through the bone marrow and associated stem cells that boost the healing process.
The availability of alternate wound healing products is projected to hamper the market growth in the forecast period. Other limitations include surgical site infection, high-cost antibacterial equipment, and cross-hatched marks. Further, the lack of reimbursement policies for wound management in developing countries is anticipated to inhibit market growth in the forthcoming time.
However, the introduction of advanced products is likely to act as a significant counter to hampering causes and thus, propelling the market growth. In April 2021, Dolphin Sutures announced the launch of a non-absorbable polytetrafluorethylene (PTFE) suture.
Principal Consultant
As per the analysis, the global knotless tissue control devices market is expected to be dominated by North America during the forecast period. In 2022, the region is estimated to garner 42.6% of the global market share.
The domination of the region can be attributed to the increasing prevalence of chronic illness, which has resulted in increased demand for surgical sutures. Also, presence of leading players in the USA like Ethicon US LLC, are focusing on technologically innovating their devices.
According to the analysis, Europe is expected to be the second-largest market for knotless tissue control devices. In 2022, the region is anticipated to secure about 28.5% of the global market share.
The growth of the market can be attributed to the developed healthcare infrastructure in the UK, Germany, and the introduction of developed suturing equipment by Smith and Nephew. As per National Joint Registry, about 160,000 hip and knee replacement surgeries are performed annually in Wales and England.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
According to the analysis, Asia-Pacific is anticipated to be the most lucrative market for knotless tissue control devices during the forecast period.
The growth of the market can be attributed to the increasing prevalence of gynecological and cardiovascular diseases accelerating the number of surgeries and procedures. Also, increasing awareness of advanced surgical devices and the growing focus of players to gain a competitive edge in developing countries of the region are expected to support the market growth. According to an analysis, about 1,453 surgical procedures are performed every year per 100,000 population in India.
Dalent Medical, OTTek, Fasciotens, Edge Surgical, Medical Micro instruments, Imbed Biosciences, Grapheal, Axio, Guard Medical, Gecko, Adhesys Medical, Kerecis, and Acera Surgical are some of the emerging entities in the global knotless tissue control devices market.
Emerging entities are making a significant contribution to the market. For instance, Acera Surgical offers synthetic electrospun scaffolds for regenerative medical applications. The company develops products that include a pliable, soft, white, porous polymer matrix, another to be used with tensionless sutures, and a soft, non-friable, absorbable matrix that acts as a protective covering for wound defects. The company received FDA clearance for its products. Thus, startups are likely to make a significant contribution to developing the market in the forecast period.
Key players in the global knotless tissue control devices market include Johnson & Johnson Services, Inc., Medtronic, and Ethicon US, LLC. (Subsidiary of Johnson & Johnson), and Medline Industries, Inc.
| Report Attribute | Details |
|---|---|
| Growth Rate (2022 to 2032) | 3.4% |
| Market Value in 2022 | US$ 465.6 Million |
| Market Value in 2032 | US$ 672.6 Million |
| Base Year for Estimation | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | USD Million for Value |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization Scope | Available upon Request |
The global knotless tissue control devices market is expected to secure US$ 672.6 Million by 2032.
The global knotless tissue control devices market is projected to display a CAGR of 3.4% during the forecast period.
Johnson & Johnson Services, Inc., and Medtronic, are some of the eminent players in the global knotless tissue control devices market.
1. Executive Summary | Knotless Tissue Control Devices Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2016 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2016 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2016 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032
5.3.1. Short-Term
5.3.2. Long-Term
5.3.3. Nonabsorbable Polymers
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2016 to 2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032
6. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2016 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers
6.3.3. Trauma Centers
6.3.4. Medical Device Manufacturers
6.3.5. Pharmaceutical Companies
6.3.6. Research Centers and Laboratory
6.4. Y-o-Y Growth Trend Analysis By End User, 2016 to 2021
6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
7. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2016 to 2021
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
8.2.1. By Country
8.2.1.1. United States of America
8.2.1.2. Canada
8.2.2. By Product Type
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product Type
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By End User
9.4. Key Takeaways
10. Europe Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Product Type
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By End User
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. India
11.2.1.5. Malaysia
11.2.1.6. Singapore
11.2.1.7. Australia
11.2.1.8. New Zealand
11.2.1.9. Rest of Asia-Pacific (APAC)
11.2.2. By Product Type
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By End User
11.4. Key Takeaways
12. Middle East and Africa Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of Middle East and Africa
12.2.2. By Product Type
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By End User
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. United States of America
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Product Type
13.1.2.2. By End User
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Product Type
13.2.2.2. By End User
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Product Type
13.3.2.2. By End User
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Product Type
13.4.2.2. By End User
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Product Type
13.5.2.2. By End User
13.6. United Kingdom
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Product Type
13.6.2.2. By End User
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Product Type
13.7.2.2. By End User
13.8. Spain
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Product Type
13.8.2.2. By End User
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Product Type
13.9.2.2. By End User
13.10. China
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Product Type
13.10.2.2. By End User
13.11. Japan
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Product Type
13.11.2.2. By End User
13.12. South Korea
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Product Type
13.12.2.2. By End User
13.13. Malaysia
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Product Type
13.13.2.2. By End User
13.14. Singapore
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Product Type
13.14.2.2. By End User
13.15. Australia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Product Type
13.15.2.2. By End User
13.16. New Zealand
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Product Type
13.16.2.2. By End User
13.17. GCC Countries
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Product Type
13.17.2.2. By End User
13.18. South Africa
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By Product Type
13.18.2.2. By End User
13.19. Israel
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By Product Type
13.19.2.2. By End User
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Product Type
14.3.3. By End User
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Medtronic
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Johnson & Johnson Services, Inc.
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Ethicon US, LLC.
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Medline Industries, Inc.
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Royal Dutch Shell Plc.
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. ExxonMobil Corporation
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. PetroChina Company Limited
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. BP P.L.C.
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Explore Healthcare Insights
View Reports
Knotless Tissue Control Devices Market
